Pharmacy cost of generic liraglutide fell 47% in 2026
Published Nov 14, 2026 · version 2026-11-14 · data: CMS's NADAC weekly files from Jan 7, 2026 to Nov 11, 2026.
Finding
The NADAC for generic liraglutide (the Victoza generic, 2-pen box, NDC 00480366720) fell from $54.16 per mL in CMS's first weekly file of 2026 (Jan 7, 2026) to $28.58 per mL from Oct 21, 2026, a change of -47.2%. At 1.2 mg a day (6 mL a month) that is $324.94 a month at the start of the year and $171.50 now.13
Source: data.medicaid.gov (CMS), NADAC 2026 · our copy of Nov 14, 2026 · recomputed when this page was built
What NADAC is, and is not
- NADAC (National Average Drug Acquisition Cost) is CMS's weekly reference data on what retail pharmacies pay to buy a drug, from a survey of pharmacy invoices.2
- It is not what a patient pays: there is no pharmacy fee in it, and your price depends on how you buy. For what people pay out of pocket, see the liraglutide price page.
- The rate here is for the generic 2-pen box of liraglutide 18 mg/3 mL (LIRAGLUTIDE 2-PAK 18 MG/3 ML), priced per ml.4
The data
| Rate effective | First 2026 weekly file with it | NADAC per mL | Per month at 1.2 mg (6 mL) |
|---|---|---|---|
| 2025-12-17 | 2026-01-07 | $54.16 | $324.94 |
| 2026-01-21 | 2026-01-21 | $54.37 | $326.20 |
| 2026-02-18 | 2026-02-18 | $48.74 | $292.47 |
| 2026-03-18 | 2026-03-18 | $43.60 | $261.58 |
| 2026-04-22 | 2026-04-22 | $38.75 | $232.52 |
| 2026-05-20 | 2026-05-20 | $38.60 | $231.59 |
| 2026-06-17 | 2026-06-17 | $37.92 | $227.52 |
| 2026-07-22 | 2026-07-22 | $35.71 | $214.27 |
| 2026-08-19 | 2026-08-19 | $33.82 | $202.91 |
| 2026-09-23 | 2026-09-23 | $31.41 | $188.44 |
| 2026-10-21 | 2026-10-21 | $28.58 | $171.50 |
Method
- Dataset: CMS's NADAC (National Average Drug Acquisition Cost) 2026 on data.medicaid.gov (id fbb83258-11c7-47f5-8b18-5f8e79f7e704).
- Query: every row for NDC 00480366720, sorted by file date (the exact query). It returned 45 rows, one per weekly file of 2026 so far.
- We keep the response as a dated copy (fetched Nov 14, 2026, SHA-256 5c07e656dc1fc5ba…). This page is rebuilt from that copy: the build checks the fingerprint, recomputes every number above and stops if any differs from the published figures.
- Change = last rate ÷ first rate − 1, rounded to 0.1%. Month = 6 mL: the label's 1.2 mg daily dose for 30 days, with 18 mg in each 3 mL pen.3
- Not included: other package sizes, brand-name Victoza and Saxenda (their current NADAC is on the liraglutide page), and any patient price.
How to cite
MedCost Clear, "Pharmacy cost of generic liraglutide fell 47% in 2026", version 2026-11-14, https://medcostclear.com/data/findings/generic-liraglutide-nadac-2026/
Free to reuse under CC BY 4.0 with credit to MedCost Clear and a link to this page. NADAC itself is CMS data, published by data.medicaid.gov as public domain.
This page stays as published
A finding is dated: its numbers describe the files named above and do not change. NADAC changes weekly; the current rate is on the liraglutide page and in the GLP-1 Cost and Coverage Dataset. If we find a mistake, we fix it here and log it on the corrections page. Questions: [email protected].
Official sources for this page (4)
- data.medicaid.gov: NADAC 2026, all weekly files for NDC 00480366720 · as of Nov 14, 2026
“National Average Drug Acquisition Cost (NADAC) weekly reference data for the calendar year.”
“Initiate at 0.6 mg injected subcutaneously once daily for one week then increase to 1.2 mg daily. If additional glycemic control is required, increase the dose to 1.8 mg daily”
FDA label (DailyMed): Victoza, version 31 · as of Nov 14, 2026“2 x Liraglutide Injection pen NDC 0143-9144-02 3 x Liraglutide Injection pen NDC 0143-9144-03”
FDA label (DailyMed): liraglutide injection (Hikma), version 7 · as of Nov 14, 2026